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Abstract This paper presents a new method of measuring performance
when positives are rare and investigates whether Chomsky
like grammar
representations are useful for learning accurate comprehensible predic

tors of members of biological sequence families The positive
only learn

ing framework of the Inductive Logic Programming ILP system CPro

gol is used to generate a grammar for recognising a class of proteins
known as human neuropeptide precursors NPPs Performance is mea

sured using both predictive accuracy and a new cost function Relative
Advantage RA The RA results show that searching for NPPs by using
our best NPP predictor as a lter is more than  times more e

cient than randomly selecting proteins for synthesis and testing them
for biological activity Predictive accuracy is not a good measure of per

formance for this domain because it does not discriminate well between
NPP recognition models despite covering varying numbers of the rare
positives all the models are awarded a similar high score by predictive
accuracy because they all exclude most of the abundant negatives
  Introduction
This paper presents a new method of measuring performance when positives are
rare and attempts to answer by way of a casestudy the question of whether
grammatical representations are useful for learning from biological sequence
data We address the question by refuting the following null hypothesis
Null hypothesis The most accurate comprehensible multistrategy predictors
of biological sequence families do not employ Chomskylike grammar repre
sentations
The performance of each model is measured using a new cost function Relative
Advantage RA Section  denes RA and explains why it is used in preference
to predictive accuracy
The domain of the case study is the recognition of a class of proteins known as
human neuropeptide precursors NPPs These proteins have considerable ther
apeutic potential and are of widespread interest in the pharmaceutical industry
Our most accurate comprehensible multistrategy predictor of NPPs employs a
Chomskylike grammar representation
Multistrategy learning 	
 aims at integrating multiple strategies in a single
learning system where strategies may be inferential eg induction deduction
etc or computational Computational strategy is dened by the representational
system and the computational method used in the learning system eg decision
tree learning neural network learning etc
We refute the null hypothesis as follows A grammar is generated for a par
ticular class of biological sequences A group of features is derived from this
grammar Other groups of features are derived using other learning strategies
Amalgams of these groups are formed A recognition model is generated for each
amalgam using C
 and C
rules The null hypothesis is refuted because
 the best performance achieved using any of the models which include grammar
derived features is higher than the best performance achieved using any of
the models which do not include the grammarderived features
 this increase is statistically signicant
 the best model which includes grammarderived features is suciently more
comprehensible than the best nongrammar model
 Relative Advantage
NPPs are identied either through purely biological means or by screening ge
nomic or protein sequence databases for likely NPPs followed by biological eval
uation If we wish to go beyond using sequence homology to nd new members
of the generally small NPP families we need a recognition model for NPPs in
general However if this recognition model is poor then it may not be much better
than random sampling of sequence databases and the costbenet of any exper
imental evaluation of NPPs found by such a procedure would be prohibitively
small
In developing a general recognition model for human NPPs we are faced
with three signicant obstacles
 The number of known NPPs in the public domain databases of protein se
quence eg SWISSPROT 	 is very small in proportion to the total num
ber of sequences When we developed our method of estimating RA May
 SWISSPROT contained 

 sequences of which some  could
denitely be identied as human NPPs
 There is no guarantee that all the human NPPs in SWISSPROT have been
properly identied We estimate there may in fact be up to  NPPs in
SWISSPROT
 There is no benchmark method for NPP recognition that can be used to com
pare any new methods We must therefore compare our recognition model
with random sampling to evaluate success
This domain requires a performance measure which addresses all of these issues
For domains in which positives are rare predictive accuracy as it is normally
measured in Machine Learning assuming equal misclassication costs
 gives a poor estimate of the performance of a recognition model For instance
if a learner induces a very specic model for such a domain the predictive
accuracy of the model may be very high despite the number of true positives
being very small or even zero
 does not discriminate well between models which exclude most of the abun
dant negatives but cover varying numbers of the rare positives This is
illustrated later in this paper  see Table 

For domains in which there is no guarantee that all positives can be identied
as such assigning misclassication costs does not suce see Sect
Therefore we dene a relative advantage RA function which predicts the
reduction in cost in using the model versus random sampling In the following
the model refers to a recognition model for predicting whether a sequence is a
NPP RA 
A
B
where
A  the expected cost of nding one NPP by repeated independent random
sampling from SWISSPROT and performing a laboratory analysis of each pro
tein
B  the expected cost of nding one NPP by repeated independent random
sampling from SWISSPROT and analysing only those proteins which are pre
dicted by the learned model to be a NPP
In contrast to other measures of performance this ratio is both relevant and
meaningful to experts in the domain
RA can be dened in terms of probability as follows Let C  the cost of test
ing the biological activity of one protein via wetexperiments in the laboratory
NPP  Sequence is a NPP Rec  Model recognises sequence as a NPP
RA 
CPrNPP 
CPrNPP j Rec

PrNPP j Rec
PrNPP 

Let testing the model on test data yield the    contingency table shown in
Table a with the cells n
 
 n

 n

 and n

 Let n  n
 
 n

 n

 n

be the
number of instances in the testset
If the proportion of NPPs in the testset was known to be the same as the
proportion of NPPs in the database then we could estimate PrNPP  to be
n
 
n

n and PrNPP j Rec to be n
 
n
 
n

 These estimates cannot be
used with our method because we cannot assume that the proportion of NPPs
is the same in the testset and database
In order to derive a formula for estimating RA given both a set of positives
and a set of randoms we estimate PrNPP  and PrNPP j Rec as follows
Let S be the total number of sequences in the database of which M are NPPs
PrNPP  
no of NPPs in the database
no of sequences in the database
MS 
PrNPP j Rec  FG 
where F  no of NPPs in db which are recognised by model
and G  no of sequences in db which model predicts to be NPP
Table    Contingency table for a the test
set and b SWISS
PROT The axes
of each    matrix are labelled by the sets NPP sequences Random sequences H
Hypothesis predictions and H complement of H The cells of each matrix represent
the cardinalities of the corresponding intersections of these sets n
 
n

n

n

 n
where n is the number of instances in the test
set The total of the countsfrequencies
in the four cells of the contingency table for SWISS
PROT  S where S is the total
number of sequences in the SWISS
PROT database
a test
set
Set of test Set of test
NPP seqs Random seqs
H n
 
n

H n

n

b SWISS
PROT
NPP sequences Random sequences
in SWISS
PROT in SWISS
PROT
H
 
n
 
n
 
n


M
 
n

n

n


S M
H
 
n

n
 
n


M
 
n

n

n


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Table b shows the expected result of using the learned recognition model
on the entire SWISSPROT database From Equation  and Table b it follows
that
PrNPP jRec 

n
 
n
 
n


M

n
 
n
 
n


M 

n

n

n


S M
 Mp
 
Mp
 
SMp




where p
 
 n
 
n
 
 n

 and p

 n

n

 n

 Substituting Equations  and

 into Equation  gives
RA 
Mp
 
Mp
 
 S Mp


MS

Sp
 
Sp

Mp
 
 p



 Estimating Relative Advantage
In the following Relative Advantage over the entire population is represented
by RA in capital letters where as Relative Advantage over a sample is denoted
by lower case ie ra As the value of M is not known we estimate
P

M	

RA
Therefore we integrate Equation  with respect to M The lower limit of M is
equal to the number of known NPPs in SWISSPROT The upper limit of M is
the most probable maximum number of NPPs in SWISSPROT ie a total of the
known NPPs and those proteins which have yet to be scientically recognised as
a NPP

X
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
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We estimate
P

M	

RA by summing an estimate of the
P

M	

RA for each
instance in the testset as follows where n is the number of instances in the
testset This method has the advantage that it allows the signicance of the
dierence between the RA of two models to be gauged see Sect From the
contingency table it follows that

X
M	

ra 

n

X
i 

n
i

X
M	

ra
i


Each
P

M	

ra
i
is estimated by substituting p
 

a
ac
and p


b
bd
into
Equation  The values of a b c and d are determined by three steps
 Whatever the i value a b c and d are initially given the values of the
corresponding countsfrequencies in the contingency table for the testset
see Table a
 Each one of a b c and d is decremented providing that the value before
subtraction is greater than 
We do not decrement when the value before subtraction is zero because
this can result in p
 
or p

having negative values this does not make sense
because p
 
and p

are probabilities We do not decrement when the value is
one because this can cause p
 
or p

to have the value zero which in turn has
a highly disproportionate eect on the value of
P

M	

ra
i

 The value of either a b c or d is incremented to reect the classication of
an instance in the cell n
i

For instance if i   and all the counts in the contingency table are greater than
one then a  n
 
  b  n

 c  n

  d  n

 
Note that Steps  and  assign the same prior probability to each instance
because the eect of each step is not dependent upon which cell the current
instance belongs to Therefore this method of estimating
P

M	

RA has the
properties of a producing identically distributed random variables representing
the outcome for each instance b having a sample mean which approaches the
population mean in the limit and c having a relatively small sample variance
The nal step of our method for estimating RA is to take the mean of the
summed values
Mean RA 
P

M	

ra
i
  

P

M	

ra
i



 Assessing the Signicance of the Dierence Between the RA of
Two Models
We compare the performance of two recognition models H
 
and H

 by com
paring their
P

M	

RA values Let d be dierence in
P

M	

RA values over
the entire population ie for all the proteins in SWISSPROT and

d be the
observed dierence on the testset
d 
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H
 


X
M	
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H


Table     Contingency Table The rows of the    matrix are labelled by the
cells of the  contingency table for H
 
 The columns of the  matrix are labelled
by the cells of the  contingency table for H

 The cells of the  matrix represent
the cardinalities of the corresponding intersections of these sets
P
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where n is the number of instances in the test
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n
 
n

n

n

n
 
n
  
n
 
n
 
n
 
n

n
 
n

n

n

n

n
 
n

n

n

n

n
 
n

n

n


d 

X
M	

ra
H
 


X
M	

ra
H



d is an unbiased estimator for the true dierence because it is calculated using
an independent test set To determine whether the observed dierence is sta
tistically signicant we address the following question What is the probability
that
P

M	

RA
H
 

P

M	

RA
H

 given the observed dierence

d
If D is a random variable representing the outcome of estimating d by ran
dom sampling then according to the Central Limit Theorem 
D
is normally
distributed in the limit It has an estimated mean

d and has an estimated vari
ance of 

D
n The variance of a random variable X is 

X
 EX

EX


Therefore since D is a random variable 

D
 
D

 

D
 We calculate 
D

as
follows Let testing the model on test data yield the 
  
 contingency table
shown in Table  with the cells n
ij
 Note that only those cells shown in bold
font can have a count greater than zero because an instance cannot be both an
NPP and a Random
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
 we evaluate our null hypothesis by estimating pd 	  using the Central Limit
Theorem
Z

x 
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Z
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D
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D

p
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 Sequence Data in Biology
Research in the biological and medical sciences is being transformed by the
volume of data coming from projects which will reveal the entire genetic code
genome sequence of Homo sapiens as well as other organisms that help us
understand the genetic basis of human disease A signicant challenge in the
analysis and interpretation of genetic sequence data is the accurate recognition
of patterns that are diagnostic for known structural or functional features within
the protein Although regular expressions can describe many of these features
they have some inherent limitations as a representation of biological sequence
patterns In recent years attention has shifted towards both the use of neural
network approaches see 	 and to probabilistic models in particular hidden
Markov models see 	 Unfortunately due to the complexity of the biological
signals considerable expertise is often required to  select the optimal neural
network architecture or hidden Markov model prior to training and  under
stand the biological relevance of detailed features of the model
A general linguistic approach to representing the structure and function of
genes and proteins has intrinsic appeal as an alternative approach to probabilistic
methods because of the declarative and hierarchical nature of grammars While
linguistic methods have provided some interesting results in the recognition of
complex biological signals 	 general methods for learning new grammars from
example sentences are much less developed
We considered it valuable to investigate the application of Inductive Logic
Programming methods to the discovery of a language that would describe a par
ticularly interesting class of sequences  neuropeptide precursor proteins NPP
Unlike enzymes and other structural proteins NPPs tend to show a lower over
all sequence similarity despite some evidence of common ancestry within certain
groups This confounds pattern discovery methods that rely on multiple sequence
alignment and recognition of biological conservation Our approach is to gener
ate the contextfree deniteclausegrammar shown in Fig  We represent pro
tein sequences using the alphabet fA C D E F G H I K L M N
P Q R S T V W Yg where each letter represents a particular amino acid
residue
 Experiment
This section describes an experiment which tries to refute the null hypothesis
see Sect It describes the materials used in the experiment and the three
steps of the experimental method and presents the results
	 Materials
Data was taken from the annotated protein sequence database SWISSPROT
Our dataset
 
comprises a subset of positives ie known NPPs and a subset
of randomlyselected sequences It is not possible to identify a set of negative
examples of NPPs with certainty because there will be proteins which have yet
to be recognised scientically as a NPP The subset of positives contains all of
 
Available at ftpftpcsyorkacukpubaigDatasetsneuropeps
Table  Properties of sequences in SWISS
PROT at the time the data
set described
in Sect was prepared and in May 
At the time the data
 May 
set was prepared
Number of sequences  
Number of known human NPPs  
Most probable maximum number of human NPPs Not known 
the 

 known NPP sequences that were in SWISSPROT at the time the data
set was prepared  of the 

 precursors were reserved for the test set These
sequences are unrelated by sequence similarity to the remaining 
 The subset of
randoms contains all of the  full length human sequences in SWISSPROT
at the time the dataset was prepared  of the  randoms were reserved
for the testset
	 Method
The method may be summarised as follows A grammar is generated for NPP
sequences using CProgol 	 version 

 see Sect
 A group of features is
derived from this grammar other groups of features are derived using other
learning strategies see Sect
 Amalgams of these groups are formed A rule
set is generated for each amalgam using C
 Release  	 and C
rules

and
its performance is measured using MeanRA see Sect
 The nullhypothesis
see Sect is then tested by comparing theMeanRA achieved from the various
amalgams
During both the generation of the grammar using CProgol and the generation
of propositional rulesets using C
 and C
rules we adopt the background
information used in 	 to describe physical and chemical properties of the amino
acids
Table  summarises how some of the properties SWISSPROT changed over
the duration of the experiments described in this paper and the subsequent
preparation of this paper All the MeanRA measurements in this paper are
based on the properties as they stood at May  these were the most uptodate
values available at the time the measurements were made

Grammar Generation A NPP grammar contains rules that describe legal
neuropeptide precursors Fig  shows an example of such a grammar written
as a Prolog program This section describes how production rules for signal
peptides and neuropeptide starts middlesections and ends were generated using

The default settings of C and Crules were used

When measuring performance using MeanRA there is no requirement that the size
of the test data
set is equal to the number of known human NPPs in SWISS
PROT
nppAB	 signalAC
starCD
neuro
peptideDE
starEB
signalAC	 
neuro
peptideDE	 startDF
middleFG
endGE
startDF	 
middleFG	 
endGE	 
m
B
k p i ... k r d a g k r ...
A
signal
star
C
D
start
middle
F
G
end E
star
Fig  Grammar rules describing legal NPP sequences The rules comply with Prolog
syntax nppXY  is true if there is a precursor at the beginning of the sequence X
and it is followed by a sequence Y  The other dyadic predicates are dened similarly
starXY  is true if at the beginning of the sequence X there is some sequence of
residues whose length is not specied and which is followed by another sequence Y 
Denitions of the predicates denoted by  are to be learnt from data of known NPP
sequences
CProgol These were used to complete the contextfree deniteclausegrammar
structure shown in Fig  CProgol was used because it is the only general purpose
ML system which is both capable of generating a grammar and tolerant to the
noise present in realworld datasets Approaches which are specic to grammar
induction do not tolerate noise
The grammar to be learnt by CProgol contains dyadic nonterminals of the
form pXY which denote that property p began the sequence X and is fol
lowed by a sequence Y To learn production rules for these nonterminals from
the training set CProgol was provided with the following  Extensional de
nitions of these nonterminals  Denitions of the nonterminals star and
run star represents some sequence of unnamed residues whose length is
not specied run represents a run of residues which share a specied property
 Production rules for various domainspecic subsequences and patterns This
natural inclusion of existing biochemical knowledge illustrates how the grammar
based approach presents a powerful method for describing NPPs
Certain restrictions were placed on the length of NPPs signal peptides and
neuropeptides because pilot experiments had shown that they increased the ac
curacy of the grammar These constraints only aect the values of features de
rived from the grammar They do not constrain the value of the sequence length
feature described at the end of Sect

Feature Groups 
 The grammar features Each feature in this group is
a prediction about a NPP sequence made by parsing the sequence using the
grammar generated by CProgol 
 The SIGNALP features Each feature
in this group is a summary of the result of using SIGNALP on a sequence
SIGNALP 	 represents the preeminent automated method for predicting the
presence and location of signal peptides 
 The proportions features Each
feature in this group is a proportion of the number of residues in a given sequence
which either are a specic aminoacid or which have a specic physicochemical
property of an aminoacid 	
 The sequence length feature This feature is
the number of residues in the sequence
Propositional Learning The training and test data sets for C
 were pre
pared as follows
 Recall from Sect
 that our data comprises 

 positives and  randoms

 of the 

 positives occur in the set of  randoms As C
 is designed
to learn from a set of positives and a set of negatives these 
 positives
were removed from the set of randoms Of the 
 positives which are in
the set of randoms  are in the testset Hence the set of   

sequences were split into a training set of     and a test set
of    
 Values of the features were generated for each training and test sequence
Each sequence was represented by a data vector comprised of these feature
values and a class value  to denote a NPP and  otherwise
 Finally to ensure that there were as many  sequences as  sequences
a training set of  NPPs was obtained by sampling with replacement
Thus the training dataset input to C
 comprised    examples
No readjusting was done on the test data
Amalgams of the feature groups described in the previous section were formed
The amalgams are listed in Table 
 The following procedure was followed for
each one  training and test sets were prepared as described above  a
decision tree was generated from the training set using C
  a ruleset was
generated from this tree using C
rules 
 a  contingency table was drawn
up based on the predictions of this ruleset on the testset  MeanRA was
estimated from this contingency table
The refutation of the null hypothesis was then attempted as described in
Sect
	 Results and Analysis
Table 
 shows theMeanRA and predictive accuracy for each amalgam of feature
groups The highest MeanRA  was achieved by one of the grammar
amalgams namely the Proportions  Length  SignalP  Grammar amalgam
The best MeanRA achieved by any of the amalgams which do not include the
grammarderived features was the 
 attained by the Proportions  Length
amalgam This dierence is statistically signicant pd 	  is well below 
Table 
 shows that predictive accuracy is not a good measure of performance
for this domain because it does not discriminate well between the amalgams de
spite covering varying numbers of the rare positives all the models are awarded
Table  Estimates ofMeanRA and predictive accuracy of the amalgams of the feature
groups
Amalgam Mean RA Predictive Accuracy 
Only props  

 

Only Length  

 

Only SignalP  

 

Only Grammar  

 

Props  Length  

 

Props  SignalP  	

 

Props  Grammar 	 

 

SignalP  Grammar  

 

Length  Grammar  

 

Length  SignalP 	 

 

Length  SignalP  Grammar  

 

Props  Length  SignalP  

 

Props  Length  Grammar 		 

 

Props  SignalP  Grammar  	

 

Props  Length  SignalP  Grammar  

 
	
a similar high score by predictive accuracy because they all exclude most of
the abundant negatives
 Discussion
This paper has shown that the most accurate comprehensible multistrategy
predictors of biological sequence families employ Chomskylike grammar repre
sentations
The positiveonly learning framework of the Inductive Logic Programming
ILP system CProgol was used to generate a grammar for recognising a class
of proteins known as human neuropeptide precursors NPPs As far as these
authors are aware this is both the rst biological grammar learnt using ILP and
the rst realworld scientic application of the positiveonly learning framework
of CProgol
If one searches for a NPP by randomly selecting sequences from SWISS
PROT for synthesis and subsequent biological testing then at most only one
in every 
 sequences tested is expected to be a novel NPP Using our best
recognition model as a lter makes the search for a NPP far more ecient
Approximately one in every  of the randomly selected SWISSPROT sequences
which pass through our lter is expected to be a novel NPP
The best nongrammar recognition model does not provide any biological
insight However the best recognition model which includes grammarderived
features is broadly comprehensible and contains some intriguing associations
that may warrant further analysis This model is being evaluated as an extension
to existing methods used in SmithKline Beecham for the selection of potential
neuropeptides for use in experiments to help elucidate the biological functions
of Gprotein coupled receptors
The new cost function presented in this paper Relative Advantage RA
may be used to measure performance of a recognition model for any domain
where  the proportion of positives in the set of examples is very small 
there is no benchmark recognition method and  there is no guarantee that all
positives can be identied as such In such domains the proportion of positive
examples in the population is not known and a set of negatives cannot identied
with complete condence
We have developed a general method for assessing the signicance of the
dierence between RA values obtained in comparative trials RA is estimated
by summing the estimate of performance on each testset instance The method
uses a identically distributed random variables representing the outcome for
each instance b a sample mean which approaches the population mean in the
limit and c a relatively small sample variance
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